Iris Tam Email & Phone Number

California, United States

Devon, Pennsylvania, Us

Strategic Leader in Medical Affairs & HEOR | Building Market Access through Evidence & Value CommunicationHigh-Impact Leadership in Market Access: Lead the establishment and expansion of COEUS' Medical Affairs and HEOR capabilities by building a strong clinical and business savvy team. Develop strategies and tactics to generate, synthesize, and communicate clinical and economic evidence, demonstrating product value to support market access and improve patient outcomes.Expertise in Payer Value Communications: Provide clients with strategically written, comprehensive clinical and economic tools and communication materials that synthesize complex data for payer and formulary decision-makers (AMCP Dossiers, PIE Decks, economic models, etc.)Cross-Functional Collaboration: Partner across client teams, including Medical Affairs, Market Access, Clinical Development, Commercial, Regulatory, and Legal to deliver cohesive, evidence-backed tactical plans that align with clients’ goals.Thought Leadership & Business Development: Actively engage in client development and business growth, leveraging insights on payer strategy, medical strategy, and U.S. healthcare trends to build strong client relationships and ensure project success. Contribute to professional organizations to share best practices across the industry.

Devon, Pennsylvania, Us

Devon, Pennsylvania, Us

South San Francisco, Ca, Us

Create and lead strategies and tactics to demonstrate the value of Achaogen's portfolio, to support patient access to products, and to improve patient quality of care.- Evidence generation through health economics and outcomes research (HEOR) and real-world evidence (RWE)- Evidence synthesis of clinical and economic data into communication tools and deliverables for use with external stakeholders, e.g., AMCP dossiers, economic models, scientific slide decks, FDAMA 114 materials, etc.- Scientific communications and engagement with external stakeholders that make or influence drug policy, coverage, and reimbursement decisions: public and private payers, other managed care customers, P&T committees, hospitals, health systems, integrated delivery networks (IDN), compendia publishers, clinical practice guideline (CPG) bodies, clinical pathways, heath technology assessment (HTA) organizations, quality agencies, value assessment frameworks, and other emerging influencing entities.

San Diego, Ca, Us

Create, execute, and communicate a comprehensive strategy for synthesizing medical and business insights into a global patient access strategy and a clinical and economic value proposition for all compounds in Otonomy's development and commercialization portfolio in the otology therapeutic area. Lead best-in-industry Field Medical Team (i.e., Medical Science Liaisons [MSLs], Managed Care/Health Outcomes Liaisons [MCL/HOL]) poised to engage key opinion leaders (KOL) and health care decision makers (HCDM) across the health care landscape and continuum. Accountable for strategies and tactics that are grounded in the generation, synthesis, and communication of scientific, clinical, and economic evidence: KOL and HCDM relationship development and engagement; field-based medical strategy; health economics and outcomes research (HEOR) studies; clinical and economic value proposition and AMCP Dossier development; payer, integrated delivery network (IDN), health systems, and Pharmacy & Therapeutics (P&T) Committee and similar entities engagement; patient advocacy; patient quality of care efforts; medical and scientific evidence executive exchanges; informing clinical practice guidelines, compendia, and health technology assessment organizations; and building and leading a highly effective team. Additional responsibilities include: competitive intelligence; medical advisory boards; publication planning; medical education and grants; medical congress planning; Phase 3 and later trial design and planning; and supporting independent investigator trials. I work strategically and collaboratively with key internal partners such as Market Access, National Account Directors, Commercial Brand Marketing, Clinical Development, Regulatory, and Legal. I also have a national and international presence and involvement in external organizations (e.g., AMCP, ISPOR, DIA, GIN, ASHP, AAO-HNSF, ASPO). itam@otonomy.com

South San Francisco, California, Us

Founded and built effective team known as a unique and best-in-industry medical affairs function that critically assesses, synthesizes, and communicates clinical and economic evidence in the managed care space to credibly and optimally support product portfolio and patient access. Engaged payers and other entities that influence formulary, coverage, and reimbursement decisions (e.g., compendia publishers, clinical practice guidelines [CPG] bodies, clinical pathway vendors, health technology assessment [HTA] organizations, and health information technology [HIT] companies, and clinical content developers) to improve patient access and quality of care. Created and implemented innovative, effective, and compliant programs and processes for engaging and communicating with these external stakeholders. Cultivated positive and productive relationships internally (e.g., HEOR, Medical, Managed Markets, Commercial, Government Affairs, Legal) and externally (e.g., AMCP, DIA, ISPOR, GIN, NPC, PQA, NCCN, ASCO). Created MCMC Internship and MCMC Fellowship programs; developed and mentored pharmacy interns and fellows.

Us

Built, serviced, and managed relationships between health plan and Medical Directors at contracted medical groups in North Bay, San Francisco, South Bay, and Fresno regions. Analyzed claims data and generated reports for various pharmacy utilization management efforts. Detailed and educated physicians on clinical drug information, prescribing guidelines, and utilization management strategies.

Daly City, California, Us

Led clinical and operational programs in the pharmacy department. Designed and implemented clinical pharmacy programs, e.g., Antibiotic Monitoring, Pharmacokinetic Service, Total Parenteral Nutrition, and Therapeutic Substitution. Responsible for the Pharmacy and Therapeutics (P&T) Committee, hospital formulary management, Adverse Drug Reporting program, employee training, and JCAHO inspections. Collaborated with other departments in multidisciplinary teams, committees, and projects. Implemented and managed automated dispensing (PYXIS) and pharmacy information systems (Cerner). Reorganized and streamlined operations; supervised and managed 25 pharmacists and 20 technicians.

Pharm.D., Pharmacy

Specialized Residency, Hospital Pharmacy Administration Residency

Residency, Clinical Pharmacy Residency

B.A., Microbiology And Immunology